Drug Prices
AHA President and CEO Rick Pollack and AARP CEO Jo Ann Jenkins today authored an OpEd in The Hill discussing the skyrocketing costs of prescription drugs and what they mean for patients and our health care system.
The number of U.S. retail opioid prescriptions fell by 10.2% in 2017, including a 16.1% decline in high-dose prescriptions, according to a report released today by the IQVIA Institute for Human Data Science.
Also in this week’s roundup: Maine hospital named for Barbara Bush recognizes her passing and University of Virginia Medical Center uses app to communicate with non-English speaking patients.
Coastal Meds LLC, which compounds drugs as an outsourcing facility, has voluntarily recalled all of its products marketed as sterile due to visible particles in some of the drug vials for injection.
The price of the 20 most prescribed brand-name drugs in the Medicare Part D program increased an average 12% per year between 2012 and 2017, about 10 times more than the average annual rate of inflation.
AHA Statement before the Senate Committee on Health, Education, Labor and Pensions Re: Perspectives on the 340B Drug Pricing Program
The Campaign for Sustainable Rx Pricing released a digital and television ad urging Congress to pass the Creating and Restoring Equal Access to Equivalent Samples Act to lower drug prices.
Also in this week’s roundup: Intermountain Healthcare’s efforts to extend medical services outside of traditional hospital walls; and a new survey showing more patients wanting access to digital health care.
WASHINGTON, DC (March 1, 2018) – Hospitals of all kinds provide a full range of benefits to their communities. In a new analysis released today, the ºÚÁÏÕýÄÜÁ¿ Associati
The U.S. health care system is facing a prescription drug spending crisis fueled by staggering increases in recent years in the price of drugs.